Bahl & Gaynor Inc. boosted its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 19.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,038 shares of the company’s stock after acquiring an additional 2,410 shares during the period. Bahl […]

Related Keywords

Canada , United States , Spencers Lee , Kevinj Mcnamara , , Fifth Third Bancorp , Chemed Corporation , Asset Management One Co , Royal Bank , Chemed Co , Deutsche Bank , Ballentine Partners , Bahl Gaynor Inc , Securities Exchange Commission , Third Bancorp , Free Report , Management One , Get Free Report , Chemed Daily , Schemed , Nyse Che , Oche , Medical , 16359r10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,